Solid pancreatic lesions of 20 mm or less Pancreas
Conditions
Interventions
Sponsors
Ishikawa Takuya
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Cases with contrast-enhanced CT/MRI/EUS showing a solid lesion of 20 mm or less in the pancreas, with EUS-FNB histology scheduled and judged to be surgically resectable.However, unresectable lesions of 10 mm or less are also included. Patients must be at least 18 years old at the time of registration. Patients who have not used antithrombotic drugs within one week, or who are able to withdraw or use alternative therapies. Patients who have given written consent to participate in the study.
Exclusion criteria
Exclusion criteria: Cases in which withdrawal or substitution of antithrombotic drugs is difficult. Patients with poorly controlled infections. Pregnancy or possible pregnancy and lactating women. Cases with severe mental disorders. Cases in which tissue samples are taken in anticipation of gene panel testing. Cases in which the principal investigator or research assistant deems the study to be unsuitable for safe conduct.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Diagnostic capability for lesions of 20 mm or less. | — |
Secondary
| Measure | Time frame |
|---|---|
| Diagnostic performance for lesions less than 15 mm Diagnostic performance for lesions larger than 15 mm and smaller than 20 mm Diagnostic performance for small lesions of 10 mm or less. Diagnostic performance by lesion site. The specimen volume is assessed using a high performancemicroscope (BZ-X800). The proportion of 22-gauge to 25-gauge or 25-gauge to 22-gauge needles changed during the examination and whether this adds to the diagnostic performance. Rate of adverse events. | — |
Contacts
Public ContactTakuya Ishikawa
Nagoya University Hospital
Outcome results
None listed